Chronic cardiotoxicity assessment of BMS-986094, a guanosine nucleotide analogue, using human iPS cell-derived cardiomyocytes

Abstract

Predicting drug-induced side effects in the cardiovascular system is very important because it can lead to the discontinuation of new drugs/candidates or the withdrawal of marketed drugs. Although chronic assessment of cardiac contractility is an important issue in safety pharmacology, an in vitro evaluation system has not been fully developed. We previously developed an imaging-based contractility assay system to detect acute cardiotoxicity using human iPS cell-derived cardiomyocytes (hiPSC-CMs). To extend the system to chronic toxicity assessment, we examined the effects of the antihepatitis C virus (HCV) drug candidate BMS-986094, a guanosine nucleotide analogue, which was withdrawn from phase 2 clinical trials because of unexpected contractility toxicities. Additionally, we examined sofosbuvir, another nucleotide analogue inhibitor of HCV that has been approved as an anti-HCV drug. Motion imaging analysis revealed the difference in cardiotoxicity between the cardiotoxic BMS-986094 and the less toxic sofosbuvir in hiPSC-CMs, with a minimum of 4 days of treatment. In addition, we found that BMS-986094-induced contractility impairment was mediated by a decrease in calcium transient. These data suggest that chronic treatment improves the predictive power for the cardiotoxicity of anti-HCV drugs. Thus, hiPSC-CMs can be a useful tool to assess drug-induced chronic cardiotoxicity in non-clinical settings.

Lysophosphatidic Acid Promotes the Expansion of Cancer Stem Cells via TRPC3 Channels in Triple-Negative Breast Cancer

“…Total RNA was isolated from MDA-MB-231 cells using TRIzol reagent (Thermo Fisher Scientific), and quantitative real-time reverse transcription (RT)-PCR was performed using the QuantiTect SYBR Green RT-PCR Kit (QIAGEN, Hilden, German) on an ABI PRISM 7900HT sequence detection system (Applied Biosystems, Foster City, CA, USA) as previously reported [40,41]. The relative change in the amount of transcript was normalized to the mRNA levels of glyceraldehyde-3-phosphate dehydrogenase (GAPDH).…”

Accelerating cardiovascular research: recent advances in translational 2D and 3D heart models

“…Therefore, it could be concluded that BMS‐986094 has a chronical toxic effect on CMs based on changed calcium handling properties. In comparison, sofobuvir displayed only little to insignificant effects on calcium handling and contractility 21 . This underlines the potential of CM‐based 2D assays for toxicological screenings even regarding direct or chronical effects.…”

“…In comparison, sofobuvir displayed only little to insignificant effects on calcium handling and contractility. 21 This underlines the potential of CM-based 2D assays for toxicological screenings even regarding direct or chronical effects.…”

A Novel Lithocholic Acid Derivative Upregulates Detoxification-Related Genes in Human Induced Pluripotent Stem Cell-Derived Intestinal Organoids

“…Real-Time PCR Quantitative PCR (qPCR) was performed according to previous protocol using a QuantiTect SYBR Green RT-PCR Kit (Qiagen, Valencia, CA, U.S.A.) with a QuantStudio 7 Flex Real-Time PCR System (Thermo Fisher Scientific). 9,10) The used primers were listed in Table 1. Each gene level was normalized by glyceraldehyde-3-phosphate dehydrogenase (GAPDH) using the ΔΔ Ct method.…”